Sodium-Glucose Co-Transporter 2 Inhibition as a Mitochondrial Therapy for Atrial Fibrillation in Patients With Diabetes?
Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0984-0
Full Text
Open PDFAbstract
Available in full text
Date
January 7, 2020
Authors
Publisher
Springer Science and Business Media LLC